Literature DB >> 4087166

Negative power functions of time in pharmacokinetics and their implications.

M E Wise.   

Abstract

When a clearance curve in pharmacokinetic studies--and in tracer kinetics in general--is well fitted by a sum of negative exponentials of time, in very many cases the data would also be well fitted over much or all of the same period by a function of time consisting mainly of a negative power or by a gamma function. There are also instances where two such power functions can be observed in the same clearance curve. Examples are given from numerous reanalyses of published results. These facts have not been explained, except as being fortuitous, by any existing theory or model based on two or more homogeneous compartments. Theoretical and practical implications are outlined and some general recipes are put forward with a view to replacing multicompartmental analysis.

Mesh:

Substances:

Year:  1985        PMID: 4087166     DOI: 10.1007/BF01065658

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  42 in total

1.  SOME APPLICATIONS OF POWER LAW ANALYSIS TO RADIOISOTOPE STUDIES IN MAN.

Authors:  J ANDERSON; S B OSBORN; R W TOMLINSON; I WEINBREN
Journal:  Phys Med Biol       Date:  1963-09       Impact factor: 3.609

2.  [Method for the measurement of the principal routes of calcium metabolism in man].

Authors:  J P AUBERT; G MILHAUD
Journal:  Biochim Biophys Acta       Date:  1960-03-25

3.  Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT.

Authors:  P V Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

4.  Curve fitting and modeling in pharmacokinetics.

Authors:  K T Muir; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1979-12

5.  Modelling of initial distribution of drugs following intravenous bolus injection.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

7.  Numerical deconvolution by least squares: use of prescribed input functions.

Authors:  D J Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1978-06

8.  A critique of compartmental analysis.

Authors:  K Zierler
Journal:  Annu Rev Biophys Bioeng       Date:  1981

9.  Fitting and interpreting dynamic tracer data.

Authors:  M E Wise
Journal:  Clin Sci (Lond)       Date:  1979-05       Impact factor: 6.124

10.  Disposition of synethetic glucocorticoids. I. Pharmacokinetics of dexamethasone in healthy adults.

Authors:  S E Tsuei; R G Moore; J J Ashley; W G McBride
Journal:  J Pharmacokinet Biopharm       Date:  1979-06
View more
  26 in total

1.  Multivariate statistics of disposition pharmacokinetic parameters for structurally unrelated drugs used in therapeutics.

Authors:  Vangelis Karalis; Anna Tsantili-Kakoulidou; Panos Macheras
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

Review 2.  Systems dynamics in clinical pharmacokinetics. An introduction.

Authors:  J M van Rossum; J E de Bie
Journal:  Clin Pharmacokinet       Date:  1989-07       Impact factor: 6.447

3.  Pharmacokinetic/pharmacodynamic modelling of NSAIDs in a model of reversible inflammation in the cat.

Authors:  Jerome M Giraudel; Armelle Diquelou; Valerie Laroute; Peter Lees; Pierre-Louis Toutain
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

4.  Fractional kinetics in drug absorption and disposition processes.

Authors:  Aristides Dokoumetzidis; Panos Macheras
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-04-02       Impact factor: 2.745

5.  Exponential tails of drug disposition curves: reality or appearance?

Authors:  Michael Weiss
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-12-13       Impact factor: 2.745

6.  Pharmacokinetic-pharmacodynamic modelling of the analgesic effects of lumiracoxib, a selective inhibitor of cyclooxygenase-2, in rats.

Authors:  D A Vásquez-Bahena; U E Salazar-Morales; M I Ortiz; G Castañeda-Hernández; Iñaki F Trocóniz
Journal:  Br J Pharmacol       Date:  2009-12-02       Impact factor: 8.739

7.  The changing face of the rate concept in biopharmaceutical sciences: from classical to fractal and finally to fractional.

Authors:  Aristides Dokoumetzidis; Panos Macheras
Journal:  Pharm Res       Date:  2011-01-25       Impact factor: 4.200

8.  Pharmacokinetic stochastic model with Weibull-distributed residence times of drug molecules in the body.

Authors:  V K Piotrovskii
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

9.  A method for the retrospective estimation of the individual respiratory intake of a highly and a poorly metabolising solvent during rest and physical exercise.

Authors:  J J Opdam; J F Smolders
Journal:  Br J Ind Med       Date:  1989-04

10.  Semi-mechanistic modelling of the analgesic effect of gabapentin in the formalin-induced rat model of experimental pain.

Authors:  A Taneja; I F Troconiz; M Danhof; O Della Pasqua
Journal:  Pharm Res       Date:  2013-10-05       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.